<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Dahlenborg, K.</title>
    <link>http://repub.eur.nl/res/aut/2148/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Function of Bruton's tyrosine kinase during B cell development is partially independent of its catalytic activity (Article)</title>
      <link>http://repub.eur.nl/res/pub/10244/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>The Tec family member Bruton's tyrosine kinase (Btk) is a cytoplasmic
      protein tyrosine kinase that transduces signals from the pre-B and B cell
      receptor (BCR). Btk is involved in pre-B cell maturation by regulating
      IL-7 responsiveness, cell surface phenotype changes, and the activation of
      lambda L chain gene rearrangements. In mature B cells, Btk is essential
      for BCR-mediated proliferation and survival. Upon BCR stimulation, Btk is
      transphosphorylated at position Y551, which promotes its catalytic
      activity and subsequently results in autophosphorylation at position Y223
      in the Src homology 3 domain. To address the significance of Y223
      autophosphorylation and the requirement of enzymatic activity for Btk
      function in vivo, we generated transgenic mice that express the
      autophosphorylation site mutant Y223F and the kinase-inactive mutant
      K430R, respectively. We found that Y223 autophosphorylation was not
      required for the regulation of IL-7 responsiveness and cell surface
      phenotype changes in differentiating pre-B cells, or for peripheral B cell
      differentiation. However, expression of the Y223F-Btk transgene could not
      fully rescue the reduction of lambda L chain usage in Btk-deficient mice.
      In contrast, transgenic expression of kinase-inactive K430R-Btk completely
      reconstituted lambda usage in Btk-deficient mice, but the defective
      modulation of pre-B cell surface markers, peripheral B cell survival, and
      BCR-mediated NF-kappaB induction were partially corrected. From these
      findings, we conclude that: 1) autophosphorylation at position Y223 is not
      essential for Btk function in vivo, except for regulation of lambda L
      chain usage, and 2) during B cell development, Btk partially acts as an
      adapter molecule, independent of its catalytic activity.</description>
    </item> <item>
      <title>Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells (Article)</title>
      <link>http://repub.eur.nl/res/pub/8407/</link>
      <pubDate>2003-01-01T00:00:00Z</pubDate>
      <description>Expression of the pre-B cell receptor (pre-BCR) leads to activation of the
      adaptor molecule SLP-65 and the cytoplasmic kinase Btk. Mice deficient for
      one of these signaling proteins have an incomplete block in B cell
      development at the stage of large cycling pre-BCR+CD43+ pre-B cells. Our
      recent findings of defective SLP-65 expression in approximately 50% of
      childhood pre-B acute lymphoblastic leukemias and spontaneous pre-B cell
      lymphoma development in SLP-65-/- mice demonstrate that SLP-65 acts as a
      tumor suppressor. To investigate cooperation between Btk and SLP-65, we
      characterized the pre-B cell compartment in single and double mutant mice,
      and found that the two proteins have a synergistic role in the
      developmental progression of large cycling into small resting pre-B cells.
      We show that Btk/SLP-65 double mutant mice have a dramatically increased
      pre-B cell tumor incidence ( approximately 75% at 16 wk of age), as
      compared with SLP-65 single deficient mice (&lt;10%). These findings
      demonstrate that Btk cooperates with SLP-65 as a tumor suppressor in pre-B
      cells. Furthermore, transgenic low-level expression of a constitutive
      active form of Btk, the E41K-Y223F mutant, prevented tumor formation in
      Btk/SLP-65 double mutant mice, indicating that constitutive active Btk can
      substitute for SLP-65 as a tumor suppressor.</description>
    </item> <item>
      <title>Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse (Article)</title>
      <link>http://repub.eur.nl/res/pub/9639/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Bruton's tyrosine kinase (Btk) is a nonreceptor tyrosine kinase involved
          in precursor B (pre-B) cell receptor signaling. Here we demonstrate that
          Btk-deficient mice have an approximately 50% reduction in the frequency of
          immunoglobulin (Ig) lambda light chain expression, already at the immature
          B cell stage in the bone marrow. Conversely, transgenic mice expressing
          the activated mutant Btk(E41K) showed increased lambda usage. As the
          kappa/lambda ratio is dependent on (a) the level and kinetics of kappa and
          lambda locus activation, (b) the life span of pre-B cells, and (c) the
          extent of receptor editing, we analyzed the role of Btk in these
          processes. Enforced expression of the Bcl-2 apoptosis inhibitor did not
          alter the Btk dependence of lambda usage. Crossing 3-83mudelta
          autoantibody transgenic mice into Btk-deficient mice showed that Btk is
          not essential for receptor editing. Also, Btk-deficient surface Ig(+) B
          cells that were generated in vitro in interleukin 7-driven bone marrow
          cultures manifested reduced lambda usage. An intrinsic defect in lambda
          locus recombination was further supported by the finding in Btk-deficient
          mice of reduced lambda usage in the fraction of pre-B cells that express
          light chains in their cytoplasm. These results implicate Btk in the
          regulation of the activation of the lambda locus for V(D)J recombination
          in pre-B cells.</description>
    </item>
  </channel>
</rss>